Testosterone may influence left ventricular diastolic function depending on previous myocardial infarction and smoking

International Journal of Cardiology

Volumn 186, Issue , 2015, Pages 67-71

  Čulić, Viktor ^a,b   Bušić, Željko ^a  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

Diastolic function; Echocardiography; Male sex; Myocardial infarction; Smoking; Testosterone

Indexed keywords

TESTOSTERONE;

ACUTE HEART FAILURE; AGED; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC KIT; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HOSPITALIZATION; HUMAN; IMMUNOASSAY; KIDNEY FUNCTION; LETTER; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS; TESTOSTERONE BLOOD LEVEL; BLOOD; DIASTOLE; FOLLOW UP; PHYSIOLOGY; RETROSPECTIVE STUDY;

AGED; DIASTOLE; FOLLOW-UP STUDIES; HUMANS; MALE; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; SMOKING; TESTOSTERONE; VENTRICULAR FUNCTION, LEFT;

EID: 84929153442     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2015.03.238     Document Type: Article

References (51)

1. V. Čulić Androgens in cardiac fibrosis and other cardiovascular mechanisms Int. J. Cardiol. 179 2015 190 192
2. P.M. Oskui, W.J. French, M.J. Herring, G.S. Mayeda, S. Burstein, and R.A. Kloner Testosterone and the cardiovascular system: a comprehensive review of the clinical literature J. Am. Heart Assoc. 2 2013 e000272
3. M. Toma, F.A. McAlister, and E.E. Coglianese Testosterone supplementation in heart failure: a meta-analysis Circ. Heart Fail. 5 2012 315 321
4. A.B. Araujo, J.M. Dixon, E.A. Suarez, M.H. Murad, L.T. Guey, and G.A. Wittert Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis J. Clin. Endocrinol. Metab. 96 2011 3007 3019
5. P.J. Angell, N. Chester, and D.J. Green Anabolic steroid use and longitudinal, radial, and circumferential cardiac motion Med. Sci. Sports Exerc. 44 2012 583 590
6. N.A. Hassan, M.F. Salem, and M.A. Sayed Doping and effects of anabolic androgenic steroids on the heart: histological, ultrastructural, and echocardiographic assessment in strength athletes Hum. Exp. Toxicol. 28 2009 273 283
7. A. D'Andrea, P. Caso, and G. Salerno Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis Br. J. Sports Med. 41 2007 149 155
8. C.J. Malkin, P.J. Pugh, P.D. Morris, S. Asif, T.H. Jones, and K.S. Channer Low serum testosterone and increased mortality in men with coronary heart disease Heart 96 2010 1821 1825
9. F. Iellamo, M. Volterrani, and G. Caminiti Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study J. Am. Coll. Cardiol. 56 2010 1310 1316
10. G. Caminiti, M. Volterrani, and F. Iellamo Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure: a double-blind, placebo-controlled, randomized study J. Am. Coll. Cardiol. 54 2009 919 927
11. V. Čulić, and Ž. Bušić Severity of acute heart failure in men according to diabetes mellitus: the role of testosterone and renal dysfunction Int. J. Cardiol. 168 2013 5039 5041
12. E.A. Jankowska, B. Biel, and J. Majda Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival Circulation 114 2006 1829 1837
13. A. Moreo, G. Ambrosio, B. De Chiara, T. Tran, and S.V. Raman Influence of midwall fibrosis on diastolic dysfunction in non-ischemic cardiomyopathy Int. J. Cardiol. 163 2013 342 344
14. N.N. Kang, L. Fu, and J. Xu Testosterone improves cardiac function and alters angiotensin II receptors in isoproterenol-induced heart failure Arch. Cardiovasc. Dis. 105 2012 68 76
15. C.C. Chung, R.C. Hsu, Y.H. Kao, J.P. Liou, and Y.J. Chen Androgen attenuates cardiac fibroblasts activations through modulations of transforming growth factor-β and angiotensin II signaling Int. J. Cardiol. 176 2014 386 393
16. M. Shimazaki, K. Nakamura, and I. Kii Periostin is essential for cardiac healing after acute myocardial infarction J. Exp. Med. 205 2008 295 303
17. C.C. Chung, Y.H. Kao, Y.Y. Lu, and Y.J. Chen Reply to the letter "androgens in cardiac fibrosis and other cardiovascular mechanisms" Int. J. Cardiol. 182 2015 340 341
18. M.A. Cavasin, S.S. Sankey, A.L. Yu, S. Menon, and X.P. Yang Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction Am. J. Physiol. Heart Circ. Physiol. 284 2003 H1560 H1569
19. V. Čulić, and Ž. Bušić Testosterone levels and heart failure in obese and non-obese men Int. J. Cardiol. 176 2014 1163 1166
20. A.S. Levey, J.P. Bosch, and J.B. Lewis Modification of diet in renal disease study group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Ann. Intern. Med. 130 1999 461 470
21. S.F. Nagueh, C.P. Appleton, and T.C. Gillebert Recommendations for the evaluation of left ventricular diastolic function by echocardiography J. Am. Soc. Echocardiogr. 22 2009 107 133
22. W.J. Paulus, C. Tschope, and J.E. Sanderson How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and echocardiography associations of the European Society of Cardiology Eur. Heart J. 28 2007 2539 2550
23. S.R. Ommen Echocardiographic assessment of diastolic function Curr. Opin. Cardiol. 16 2001 240 245
24. M.A. Babyak What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models Psychosom. Med. 66 2004 411 421
25. E.W. Steyerberg, M.J. Eijkemans, F.E. Harrell Jr., and J.D. Habbema Prognostic modeling with logistic regression analysis: in search of a sensible strategy in small data sets Med. Decis. Making 21 2001 45 56
26. L. Fang, X.M. Gao, and C.S. Samuel Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction Clin. Sci. (Lond.) 115 2008 99 106
27. W.C. Tsai, T.I. Lee, and Y.C. Chen Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity Int. J. Cardiol. 176 2014 110 118
28. A. D'Alessandro, I. Boeckelmann, M. Hammwhöner, and A. Goette Nicotine, cigarette smoking and cardiac arrhythmia: an overview Eur. J. Prev. Cardiol. 19 2012 297 305
29. M.A. Talukder, W.M. Johnson, and S. Varadharaj Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice Am. J. Physiol. Heart Circ. Physiol. 300 2011 H388 H396
30. A.K. Khanna, J. Xu, and M.R. Mehra Antioxidant N-acetyl cysteine reverses cigarette smoke-induced myocardial infarction by inhibiting inflammation and oxidative stress in a rat model Lab. Investig. 92 2012 224 235
31. J.E. Tanus-Santos, R.C. Sampaio, S. Hyslop, K.G. Franchini, and H. Moreno Jr. Endothelin ET(A) receptor antagonism attenuates the pressor effects of nicotine in rats Eur. J. Pharmacol. 396 2000 33 37
32. J.M. Bradley, J.B. Nguyen, A.C. Fournett, and J.D. Gardner Cigarette smoke exacerbates ventricular remodeling and dysfunction in the volume overloaded heart Microsc. Microanal. 18 2012 91 98
33. D.B. Sawyer, D.A. Siwik, J. Xiao, D.R. Pimentel, K. Singh, and W.S. Colucci Role of oxidative stress in myocardial hypertrophy and failure J. Mol. Cell. Cardiol. 34 2002 379 388
34. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J. Am. Coll. Cardiol. 43 2004 1731 1737
35. Z.S. Kyriakides, D.T. Kremastinos, E. Rentoukas, S. Mavrogheni, D.I. Kremastinos, and P. Toutouzas Acute effects of cigarette smoking on left ventricular diastolic function Eur. Heart J. 13 1992 743 748
36. J.W. Stephens, and S.E. Humphries The molecular genetics of cardiovascular disease: clinical implications J. Intern. Med. 253 2003 120 127
37. P. de Moerloose, and F. Boehlen Inherited thrombophilia in arterial disease: a selective review Semin. Hematol. 44 2007 106 113
38. Y. Chen, P.T. Dawes, J.C. Packham, and D.L. Mattey Interaction between smoking and functional polymorphism in the TGFB1 gene is associated with ischaemic heart disease and myocardial infarction in patients with rheumatoid arthritis: a cross-sectional study Arthritis Res. Ther. 14 2012 R81
39. L.P. Breitling, K. Salzmann, D. Rothenbacher, B. Burwinkel, and H. Brenner Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease Eur. Heart J. 33 2012 2841 2848
40. C.W. Yancy, M. Jessup, B. Bozkurt American College of Cardiology Foundation American Heart Association Task Force on Practice Guidelines 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J. Am. Coll. Cardiol. 62 2013 e147 e239
41. T. Kosaka, M. Nakagawa, and M. Ishida Cardioprotective effect of an L/N-type calcium channel blocker in patients with hypertensive heart disease J. Cardiol. 54 2009 262 272
42. T. Takami, and M. Shigematsu Effects of calcium channel antagonists on left ventricular hypertrophy and diastolic function in patients with essential hypertension Clin. Exp. Hypertens. 25 2003 525 535
43. H. Ito, K. Ishii, K. Iwakura, F. Nakamura, T. Nagano, and S. Takiuchi Impact of azelnidipine treatment on left ventricular diastolic performance in patients with hypertension and mild diastolic dysfunction: multi-center study with echocardiography Hypertens. Res. 32 2009 895 900
44. H.M. Prendergast, S. Dudley, and M. Brown Antihypertensive medications and diastolic dysfunction progression in an African American population High Blood Press. Cardiovasc. Prev. 21 2014 269 274
45. N. Nishikawa, T. Masuyama, and K. Yamamoto Long-term administration of amlodipine prevents decompensation to diastolic heart failure in hypertensive rats J. Am. Coll. Cardiol. 38 2001 1539 1545
46. H. Nagai, S. Minatoguchi, and X.H. Chen Cilnidipine, an N + L-type dihydropyridine Ca channel blocker, suppresses the occurrence of ischemia/reperfusion arrhythmia in a rabbit model of myocardial infarction Hypertens. Res. 28 2005 361 368
47. S. Ohshima, S. Isobe, and H. Izawa Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients J. Am. Coll. Cardiol. 46 2005 2061 2068
48. J.G. Cleland, M. Tendera, J. Adamus, N. Freemantle, L. Polonski, and J. Taylor The perindopril in elderly people with chronic heart failure (PEP-CHF) study Eur. Heart J. 27 2006 2338 2345
49. R.B. Devereux, B. Dahlöf, and E. Gerdts Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial Circulation 110 2004 1456 1462
50. C.G. Brilla, R.C. Funck, and H. Rupp Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease Circulation 102 2000 1388 1393
51. S.D. Solomon, R. Janardhanan, A. Verma Valsartan In Diastolic Dysfunction (VALIDD) Investigators Effect of angiotensin receptor blockade and antihypertensive drugs on diastolic function in patients with hypertension and diastolic dysfunction: a randomised trial Lancet 369 2007 2079 2087